Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan

Environment International

Volumn 92-93, Issue , 2016, Pages 716-728

  Johnson, Paula I ^a   Koustas, Erica ^b   Vesterinen, Hanna M ^a   Sutton, Patrice ^a   Atchley, Dylan S ^a   Kim, Allegra N ^c   Campbell, Marlissa ^c   Donald, James M ^c   Sen, Saunak ^d   Bero, Lisa ^a,e   Zeise, Lauren ^c   Woodruff, Tracey J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e University of Sydney   (Australia)

Author keywords

Antibacterial; Personal care; Policy; Risk assessment; Soap; Thyroid

Indexed keywords

CELL PROLIFERATION; HORMONES; NAVIGATION; PUBLIC POLICY; RATS; RISK ASSESSMENT; SOAPS (DETERGENTS); TOXICITY;

ANTIBACTERIAL; DEVELOPMENTAL TOXICITY; HORMONE CONCENTRATION; PERSONAL CARE; POSTNATAL EXPOSURE; REPRODUCTIVE HEALTH; REPRODUCTIVE TOXICITIES; THYROID;

QUALITY CONTROL;

THYROXINE; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

CONCENTRATION (COMPOSITION); HEALTH IMPACT; HORMONE; META-ANALYSIS; PESTICIDE; RISK ASSESSMENT; TOXICITY;

ARTICLE; BLOOD TOXICITY; DEVELOPMENTAL TOXICITY; ENVIRONMENTAL EXPOSURE; EXPOSURE; FETUS RESORPTION; FETUS WASTAGE; HUMAN; NEUROTOXICITY; NEWBORN DEATH; NONHUMAN; POPULATION EXPOSURE; POSTNATAL EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; STILLBIRTH; SYSTEMATIC REVIEW (TOPIC); THYROXINE BLOOD LEVEL; ANIMAL; DRUG EFFECTS; FETUS DEVELOPMENT; META ANALYSIS; METABOLISM; POLLUTANT; RAT; TOXICITY;

MAMMALIA; RATTUS;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ENVIRONMENTAL POLLUTANTS; FETAL DEVELOPMENT; HUMANS; RATS; THYROXINE; TRICLOSAN;

EID: 85027917968     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2016.03.009     Document Type: Article

References (85)

1. Adolfsson-Erici, M., Pettersson, M., Parkkonen, J., Sturve, J., Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46 (2002), 1485–1489.
2. Aiello, A.E., Larson, E.L., Levy, S.B., Consumer antibacterial soaps: effective or just risky?. Clin. Infect. Dis. 45:Suppl. 2 (2007), S137–S147.
3. Allmyr, M., Panagiotidis, G., Sparve, E., Diczfalusy, U., Sandborgh-Englund, G., Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones. Basic Clin. Pharmacol. Toxicol. 105 (2009), 339–344.
4. The Alliance for the Prudent Use of Antibiotics, Triclosan. 2011, Author, Boston, MA.
5. Axelstad, M., Boberg, J., Vinggaard, A.M., Christiansen, S., Hass, U., Triclosan exposure reduces thyroxine levels in pregnant and lactating rat dams and in directly exposed offspring. Food Chem. Toxicol. 59 (2013), 534–540.
6. Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 64 (2011), 401–406.
7. Bebarta, V., Luyten, D., Heard, K., Emergency medicine animal research: does use of randomization and blinding affect the results?. Acad. Emerg. Med. 10 (2003), 684–687.
8. Bertelsen, R.J., Engel, S.M., Jusko, T.A., Calafat, A.M., Hoppin, J.A., London, S.J., et al. Reliability of triclosan measures in repeated urine samples from Norwegian pregnant women. J. Exposure Sci. Environ. Epidemiol. 24 (2014), 517–521.
9. Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A., Needham, L.L., Urinary concentrations of triclosan in the US population: 2003–2004. Environ. Health Perspect. 116 (2008), 303–307.
10. Chen, M., Tang, R., Fu, G., Xu, B., Zhu, P., Qiao, S., et al. Association of exposure to phenols and idiopathic male infertility. J. Hazard. Mater. 250–251 (2013), 115–121.
11. Ciba Specialty Chemicals Corporation, Triclosan Safety Studies Submitted to OTC Docket 81 N-033P. 2004, U.S. Food and Drug Administration, Washington, D.C.
12. Cooney, C.M., Triclosan comes under scrutiny. Environ. Health Perspect., 118, 2010, A242-A.
13. Crofton, K.M., Thyroid disrupting chemicals: mechanisms and mixtures. Int. J. Androl. 31 (2008), 209–223.
14. Crofton, K.M., Paul, K.B., Devito, M.J., Hedge, J.M., Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine. Environ. Toxicol. Pharmacol. 24 (2007), 194–197.
15. Cullinan, M.P., Palmer, J.E., Carle, A.D., West, M.J., Seymour, G.J., Long term use of triclosan toothpaste and thyroid function. Sci. Total Environ. 416 (2012), 75–79.
16. Dann, A.B., Hontela, A., Triclosan: environmental exposure, toxicity and mechanisms of action. J. Appl. Toxicol. 31 (2011), 285–311.
17. Fang, J.L., Stingley, R.L., Beland, F.A., Harrouk, W., Lumpkins, D.L., Howard, P., Occurrence, efficacy, metabolism, and toxicity of triclosan. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 28 (2010), 147–171.
18. Foran, C.M., Bennett, E.R., Benson, W.H., Developmental evaluation of a potential non-steroidal estrogen: triclosan. Mar. Environ. Res. 50 (2000), 153–156.
19. Ghassabian, A., El Marroun, H., Peeters, R.P., Jaddoe, V.W., Hofman, A., Verhulst, F.C., et al. Downstream effects of maternal hypothyroxinemia in early pregnancy: nonverbal IQ and brain morphology in school-age children. J. Clin. Endocrinol. Metab. 99 (2014), 2383–2390.
20. Guyatt, G.H., Oxman, A.D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., et al. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). J. Clin. Epidemiol. 64 (2011), 407–415.
21. Halden, R.U., On the need and speed of regulating triclosan and triclocarban in the United States. Environ. Sci. Technol. 48 (2014), 3603–3611.
22. Health Canada, Preliminary Assessment: Triclosan Chem Abs. 2012.
23. Henrichs, J., Bongers-Schokking, J.J., Schenk, J.J., Ghassabian, A., Schmidt, H.G., Visser, T.J., et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J. Clin. Endocrinol. Metab. 95 (2010), 4227–4234.
24. Higgins, J.P.T., Green, S., Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011]: The Cochrane Collaboration. Available from www.cochrane-handbook.org.;, 2011 (Available from: Available from www.cochrane-handbook.org).
25. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). [other] 2013 [updated 2013/07/02/, 2014/03/25/21:35:21]; Available from: http://press.endocrine.org/doi/abs/10.1210/jcem.87.2.8182.
26. Holman, L., Head, M.L., Lanfear, R., Jennions, M.D., Evidence of experimental bias in the life sciences: why we need blind data recording. PLoS Biol., 13, 2015, e1002190.
27. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Preamble (amended January 2006). 2006, World Health Organization, Lyon, France.
28. James, M.O., Li, W., Summerlot, D.P., Rowland-Faux, L., Wood, C.E., Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environ. Int. 36 (2010), 942–949.
29. Johnson, P.I., Koustas, E., Vesterinen, H.M., Sutton, P., Atchley, D.S., Kim, A.N., et al. Applying the Navigation Guide Case Study #2 Reproductive and Developmental Effects of Exposure to Triclosan: A Systematic Review of the Evidence Protocol. 2013.
30. Johnson, P.I., Sutton, P., Atchley, D.S., Koustas, E., Lam, J., Sen, S., et al. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122 (2014), 1028–1039.
31. Knudsen, N., Laurberg, P., Rasmussen, L.B., Bülow, I., Perrild, H., Ovesen, L., et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J. Clin. Endocrinol. Metab. 90 (2005), 4019–4024.
32. Koeppe, E.S., Ferguson, K.K., Colacino, J.A., Meeker, J.D., Relationship between urinary triclosan and paraben concentrations and serum thyroid measures in NHANES 2007–2008. Sci. Total Environ. 445–446 (2013), 299–305.
33. Koustas, E., Lam, J., Sutton, P., Johnson, P.I., Atchley, D.S., Sen, S., et al. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122 (2014), 1015–1027.
34. Krauth, D., Woodruff, T.J., Bero, L., Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ. Health Perspect. 121 (2013), 985–992.
35. Kumar, V., Chakraborty, A., Kural, M.R., Roy, P., Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reprod. Toxicol. 27 (2009), 177–185.
36. Lam, J., Sutton, P., Koustas, E., Johnson, P., Atchley, D.S., Sen, S., et al. The Navigation Guide—evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122 (2014), 1041–1051.
37. Landis, S.C., Amara, S.G., Asadullah, K., Austin, C.P., Blumenstein, R., Bradley, E.W., et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490 (2012), 187–191.
38. Lankester, J., Patel, C., Cullen, M.R., Ley, C., Parsonnet, J., Urinary triclosan is associated with elevated body mass index in NHANES. PLoS One, 8, 2013.
39. Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O.A., Bero, L., Industry sponsorship and research outcome. Cochrane database of systematic reviews (Online). 2012, 12.
40. Macleod, M.R., O'Collins, T., Howells, D.W., Donnan, G.A., Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35 (2004), 1203–1208.
41. Mastorakos, G., Karoutsou, E.I., Mizamtsidi, M., Creatsas, G., The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development. Endocrine 31 (2007), 219–237.
42. Matsumura, N., Ishibashi, H., Hirano, M., Nagao, Y., Watanabe, N., Shiratsuchi, H., et al. Effects of nonylphenol and triclosan on production of plasma vitellogenin and testosterone in male South African clawed frogs (Xenopus laevis). Biol. Pharm. Bull. 28 (2005), 1748–1751.
43. McPartland, J.M., Glass, M., Pertwee, R.G., Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br. J. Pharmacol. 152 (2007), 583–593.
44. Miller, M.D., Crofton, K.M., Rice, D.C., Zoeller, R.T., Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ. Health Perspect. 117 (2009), 1033–1041.
45. Morreale de Escobar, G., The role of thyroid hormone in fetal neurodevelopment. J. Pediatr. Endocrinol. Metab. 14:Suppl. 6 (2001), 1453–1462.
46. National Research Council, Review of EPA's Integrated Risk Information System (IRIS) Process. 2014, National Academies Press, Washington, D.C.
47. National Research Council, Review of the Environmental Protection Agency's State-of-the-Science Evaluation of Nonmonotonic Dose–Response Relationships as They Apply to Endocrine Disruptors. 2014, National Academies Press, Washington, D.C.
48. National Toxicology Program, U.S. Departmentof Healthand Human Services, (eds.) Handbook for Conducting a Literature-Based Health Assessment Using OHAT Approach for Systematic Review and Evidence Integration, 2015, Office of Health Assessment and Translation, Division of National Toxicology Program, National Institute of Environmental Health Sciences.
49. Paul, K.B., Hedge, J.M., DeVito, M.J., Crofton, K., Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in young Long–Evans rats. Toxicol. Sci. 113 (2010), 367–379.
50. Paul, K.B., Hedge, J.M., DeVito, M.J., Crofton, K.M., Developmental triclosan exposure decreases maternal and neonatal thyroxine in rats. Environ. Toxicol. Chem. 29 (2010), 2840–2844.
51. Paul, K.B., Hedge, J.M., Bansal, R., Zoeller, R.T., Peter, R., DeVito, M.J., et al. Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action. Toxicology 300 (2012), 31–45.
52. Paul, K.B., Thompson, J.T., Simmons, S.O., Vanden Heuvel, J.P., Crofton, K.M., Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors. Toxicol. in Vitro 27 (2013), 2049–2060.
53. Perencevich, E.N., Wong, M.T., Harris, A.D., National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am. J. Infect. Control 29 (2001), 281–283.
54. Robertshaw, H., Leppard, B., Contact dermatitis to triclosan in toothpaste. Contact Dermatitis, 57, 2007 383-3U4.
55. Rodricks, J.V., Swenberg, J.A., Borzelleca, J.F., Maronpot, R.R., Shipp, A.M., Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol. 40 (2010), 422–484.
56. Rodriguez, P.E., Sanchez, M.S., Maternal exposure to triclosan impairs thyroid homeostasis and female pubertal development in Wistar rat offspring. J. Toxic. Environ. Health A 73 (2010), 1678–1688.
57. Rooney, A.A., Boyles, A.L., Wolfe, M.S., Bucher, J.R., Thayer, K.A., Systematic review and evidence integration for literature-based environmental health science assessments. Environ. Health Perspect., 2014.
58. Sawaya, G.F., Guirguis-Blake, J., LeFevre, M., Harris, R., Petitti, D., Update on methods: estimating certainty and magnitude of net benefit. U.S. Preventive Services Task Force., 2007 Available from: http://www.uspreventiveservicestaskforce.org/uspstf07/methods/benefit.htm#copyright.
59. SCCS. Scientific Committee on Consumer Safety, Addendum to SCCP Opinion on Triclosan. 2011.
60. Schena, D., Papagrigoraki, A., Girolomoni, G., Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol. Ther., 21, 2008 S35-SS8.
61. Stoker, T.E., Gibson, E.K., Zorrilla, L.M., Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol. Sci. 117 (2010), 45–53.
62. Teitelbaum, S.L., Britton, J.A., Calafat, A.M., Ye, X., Silva, M.J., Reidy, J.A., et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ. Res. 106 (2008), 257–269.
63. The National Academies, Project information: review of the IRIS process. Washington, D.C., 2012 [cited 2012 June 21]; Available from: http://www8.nationalacademies.org/cp/projectview.aspx?key=49458.
64. U.S. Environmental Protection Agency, Guidelines for Developmental Toxicity Risk Assessment. 1991, U.S. Environmental Protection Agency, Washington, D.C. ([cited 2014 27 February]; Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=23162#Download).
65. U.S. Environmental Protection Agency, Guidelines for Reproductive Toxicity Risk Assessment. 1996, U.S. Environmental Protection Agency, Washington, D.C. ([cited 2014 27 February]; Available from: http://www.epa.gov/raf/publications/pdfs/REPRO51.PDF).
66. U.S. EPA, Office of Pesticide Programs. Pesticide reregistration status | Pesticides | US EPA. U.S. EPA, Office of Pesticide Programs. [updated 2015/01/19; cited 2015 July 23]; Available from: http://www.epa.gov/pesticides/reregistration/status.htm, 2015.
67. U.S. Food and Drug Administration, Services UDoHaH, (eds.) Federal Register: Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record; Proposed Rule, 2013 (Washington D.C.).
68. US Environmental Protection Agency, Draft development materials for the integrated risk information system (IRIS) toxicological review of inorganic arsenic: bimonthly public meeting: June 2014. EPA U, (eds.) Washington. U. S. Environmental Protection Agency, D.C. (78 FR 76443), 2014 Available at: https://federalregister.gov/a/2013-29814.
69. van der Worp, H.B., Macleod, M.R., Preclinical studies of human disease: time to take methodological quality seriously. J. Mol. Cell. Cardiol. 51 (2011), 449–450.
70. van der Worp, H.B., Sena, E.S., Donnan, G.A., Howells, D.W., Macleod, M.R., Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 130 (2007), 3063–3074.
71. Veldhoen, N., Skirrow, R.C., Osachoff, H., Wigmore, H., Clapson, D.J., Gunderson, M.P., et al. The bactericidal agent triclosan modulates thyroid hormone-associated gene expression and disrupts postembryonic anuran development. Aquat. Toxicol., 83, 2007, 84.
72. Vesterinen, H.M., Egan, K., Deister, A., Schlattmann, P., Macleod, M.R., Dirnagl, U., Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J. Cereb. Blood Flow Metab. 31 (2011), 1064–1072.
73. Vesterinen, H.M., Johnson, P.I., Koustas, E., Lam, J., Sutton, P., Woodruff, T.J., In support of EHP's proposal to adopt the ARRIVE guidelines. Environ. Health Perspect., 121, 2013, A325-A.
74. Vesterinen, H., Johnson, P., Atchley, D., Sutton, P., Lam, J., Zlatnik, M., et al. The relationship between fetal growth and maternal glomerular filtration rate: a systematic review. J. Matern-Fetal Neonatal Med., 1–6, 2014.
75. Viswanathan, M., Ansari, M., Berkman, N., Chang, S., Hartling, L., McPheeters, L., et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. Report No.: AHRQ Publication No. 12-EHC047-EF, 2012.
76. Whaley, P.W., Systematic Review and the Future of Evidence in Chemicals Policy: Réseau Environnement Santé. 2013.
77. Wilding, B.C., Curtis, K., Welker-Hood, K., Hazardous Chemicals in Health Care: A Snapshot of Chemicals in Doctors and Nurses. 2009, Physicians for Social Responsibility, Washington, D.C.
78. Wise, A., Parham, F., Axelrad, D.A., Guyton, K.Z., Portier, C., Zeise, L., et al. Upstream adverse effects in risk assessment: a model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans. Environ. Res. 117 (2012), 90–99.
79. Witorsch, R.J., Critical analysis of endocrine disruptive activity of triclosan and its relevance to human exposure through the use of personal care products. Crit. Rev. Toxicol. 44 (2014), 535–555.
80. Wolff, M.S., Teitelbaum, S.L., Windham, G., Pinney, S.M., Britton, J.A., Chelimo, C., et al. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ. Health Perspect. 115 (2007), 116–121.
81. Wolff, M.S., Teitelbaum, S.L., Pinney, S.M., Windham, G., Liao, L., Biro, F., et al. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ. Health Perspect. 118 (2010), 1039–1046.
82. Woodruff, T.J., Sutton, P., The Navigation Guide work group. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Aff. (Millwood) 30 (2011), 931–937.
83. Woodruff, T.J., Sutton, P., The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes. Environ. Health Perspect., 122, 2014, A283.
84. Woodruff, T.J., Zeise, L., Axelrad, D.A., Guyton, K.Z., Janssen, S., Miller, M., et al. Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ. Health Perspect. 116 (2008), 1568–1575.
85. Zorrilla, L.M., Gibson, E.K., Jeffay, S.C., Crofton, K.M., Setzer, W.R., Cooper, R.L., et al. The effects of triclosan on puberty and thyroid hormones in male Wistar rats. Toxicol. Sci. 107 (2009), 56–64.